EP-092

N/A

Report date: 2022/08/24 16:27:11

Base Information

Drug NameEP-092
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThromboxane A2 receptor antagonists
TargetsThromboxane A2 receptor
Therapy Area/IndicationsThrombosisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A